1988
DOI: 10.1177/000456328802500105
|View full text |Cite
|
Sign up to set email alerts
|

Design of the Immunogen and Label for Use in a Fluoroimmunoassay for Paracetamol

Abstract: The design of immunogens for raising antisera containing antibodies specifically directed against paracetamol is discussed. A derivative of the drug with minimal structural alteration was synthesised, coupled to the carrier protein key-hole limpet haemocyanin, and used to immunise sheep. The evaluation of the resulting antisera is described. Preparation of a fluorescent label with reduced bridge-binding then allowed the development of a polarisation fluoroimmunoassay for paracetamol in buffer, suitable for con… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
1
0

Year Published

1990
1990
2011
2011

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 10 publications
(2 citation statements)
references
References 4 publications
1
1
0
Order By: Relevance
“…fore, suggests real, albeit small, variation in the ability of the IgG preparations to bind substrate. The magnitude of the variation in K , is similar to that of the binding characteristics of non-catalytic antibodies produced by using carefully prepared immunogens (El-Gamal et al, 1987) and an immunisation schedule (Bennett et al, 1987;Gallacher et al, 1988;Mellor et al, 1989) analogous to that used in the present work. Variation in the binding characteristics of non-catalytic antibodies during an immunisation schedule has recently been subjected to detailed analysis by Foote and Milstein (1991).…”
Section: Additional Evidence That the Catalytic Activity Of Igg Prepasupporting
confidence: 65%
“…fore, suggests real, albeit small, variation in the ability of the IgG preparations to bind substrate. The magnitude of the variation in K , is similar to that of the binding characteristics of non-catalytic antibodies produced by using carefully prepared immunogens (El-Gamal et al, 1987) and an immunisation schedule (Bennett et al, 1987;Gallacher et al, 1988;Mellor et al, 1989) analogous to that used in the present work. Variation in the binding characteristics of non-catalytic antibodies during an immunisation schedule has recently been subjected to detailed analysis by Foote and Milstein (1991).…”
Section: Additional Evidence That the Catalytic Activity Of Igg Prepasupporting
confidence: 65%
“…It seemed important to investigate the possibility of producing polyclonal catalytic antibodies for several reasons: (i) the relative simplicity of producing polyclonal as against monoclonal antibodies, (ii) the possibility of extending the catalytic antibody field to include investigation of catalytic antibody responses in animals, (iii) the possibility that if polyclonal antibody preparations that obey the Michaelis-Menten equation could be prepared, despite the overall structural heterogeneity of polyclonal IgG, they would provide a ready means of investigating a wide range of kinetic characteristics before the detailed structural studies that would necessarily demand use of monoclonal antibodies, (iv) the potential value of polyclonal catalytic antibodies as catalysts for technological applications, and (v) the potential value of catalytic antibodies produced by immunization in the development of novel therapies. The production of polyclonal antibodies that bind small molecules has been extensively investigated (Landsteiner, 1947;Pauling & Pressman, 1945), and it is possible to produce polyclonal antibodies with particular recognition features by careful design of the immunogen employed for antibody production and ofthe ligands involved in subsequent binding interactions (Bauminger et al, 1974;Gallacher et al, 1988).…”
Section: Introductionmentioning
confidence: 99%